Deep Unsupervised Clustering of Sparse Echo Data to Identify Patients for Implantation of Cardioverter-Defibrillator

Moein Enayati, N. Farahani, Christopher G. Scott, J. Bos, Xiaoxi Yao, Che Ngufor, M. Ackerman, Adelaide M. Arruda-Olson
{"title":"Deep Unsupervised Clustering of Sparse Echo Data to Identify Patients for Implantation of Cardioverter-Defibrillator","authors":"Moein Enayati, N. Farahani, Christopher G. Scott, J. Bos, Xiaoxi Yao, Che Ngufor, M. Ackerman, Adelaide M. Arruda-Olson","doi":"10.1115/dmd2022-1074","DOIUrl":null,"url":null,"abstract":"\n According to the 2020 report of the American Heart Association’s Heart & Stroke Statistics report, nearly 1,000 people are dying daily because of sudden out-of-hospital cardiac arrests and unfortunately, their survival rate is as low as 10%. Hypertrophic Cardiomyopathy (HCM), a relatively rare genetic heart disease is one of these diseases but finding the right patient for the implantation of ICD is still a research question. Implantation of cardioverter-defibrillator (ICD) can save the life of some of these patients. Due to the complexity of the identification of HCM patients, financial burdens, and the clinical risks involved in the ICD implantation procedure, HCM patients will go into a monitoring state before reaching the implantation trigger. Our study cohort shows about 82% of HCM deaths, did not have an ICD, which highlights the need to improve the pre-screening algorithms.\n In the current paper, we have proposed a new deep learning-based unsupervised clustering technique to facilitate the prioritization of patients to undergo ICD device implantation. This model uses over 900 echocardiographic measurements to find patients who benefit more from the ICD implantation procedure. Our model was trained and tested over 6 years of echo reports collected at Mayo Clinic. This model can be used as a decision support assistant for cardiologists in finding the right HCM patient when decision-making is hard.","PeriodicalId":236105,"journal":{"name":"2022 Design of Medical Devices Conference","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2022 Design of Medical Devices Conference","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1115/dmd2022-1074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

According to the 2020 report of the American Heart Association’s Heart & Stroke Statistics report, nearly 1,000 people are dying daily because of sudden out-of-hospital cardiac arrests and unfortunately, their survival rate is as low as 10%. Hypertrophic Cardiomyopathy (HCM), a relatively rare genetic heart disease is one of these diseases but finding the right patient for the implantation of ICD is still a research question. Implantation of cardioverter-defibrillator (ICD) can save the life of some of these patients. Due to the complexity of the identification of HCM patients, financial burdens, and the clinical risks involved in the ICD implantation procedure, HCM patients will go into a monitoring state before reaching the implantation trigger. Our study cohort shows about 82% of HCM deaths, did not have an ICD, which highlights the need to improve the pre-screening algorithms. In the current paper, we have proposed a new deep learning-based unsupervised clustering technique to facilitate the prioritization of patients to undergo ICD device implantation. This model uses over 900 echocardiographic measurements to find patients who benefit more from the ICD implantation procedure. Our model was trained and tested over 6 years of echo reports collected at Mayo Clinic. This model can be used as a decision support assistant for cardiologists in finding the right HCM patient when decision-making is hard.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
稀疏回波数据的深度无监督聚类识别心律转复除颤器植入术患者
根据美国心脏协会的《心脏与中风统计报告》2020年的报告,每天有近1000人死于院外心脏骤停,不幸的是,他们的存活率低至10%。肥厚性心肌病(HCM)是一种较为罕见的遗传性心脏病,但寻找合适的ICD植入患者仍然是一个研究问题。心脏转复除颤器(ICD)的植入可以挽救一些患者的生命。由于HCM患者识别的复杂性、经济负担和ICD植入过程中涉及的临床风险,HCM患者在到达植入触发点之前会进入监测状态。我们的研究队列显示,约82%的HCM死亡患者没有ICD,这突出了改进预筛查算法的必要性。在本文中,我们提出了一种新的基于深度学习的无监督聚类技术,以促进患者接受ICD装置植入的优先级。该模型使用900多个超声心动图测量来寻找从ICD植入过程中获益更多的患者。我们的模型经过了在梅奥诊所收集的6年的回声报告的训练和测试。该模型可作为心脏科医生在决策困难时寻找合适HCM患者的决策支持助手。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Communicating Cybersecurity and Privacy Design Attributes through Privacy Labeling of Consumer Electronic Medical Devices A Novel Tool for Auricle Retraction During Closure of Post-Auricular Incisions Development and Characterization of Biostable Hydrogel Robotic Actuators for Implantable Devices: Tendon Actuated Gelatin Non-Invasive Diagnosis of Deep Vein Thrombosis to Expedite Treatment and Prevent Pulmonary Embolism During Gestation Development of an Epicardial Mapping Tank for Noninvasive Electrical Mapping of Ex Vivo Large Mammalian Hearts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1